April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Pioglitazone Elicits Dilation of Isolated Porcine Arterioles
Author Affiliations & Notes
  • T. Omae
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • T. Nagaoka
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • I. Tanano
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • A. Yoshida
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • Footnotes
    Commercial Relationships  T. Omae, None; T. Nagaoka, None; I. Tanano, None; A. Yoshida, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5029. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Omae, T. Nagaoka, I. Tanano, A. Yoshida; Pioglitazone Elicits Dilation of Isolated Porcine Arterioles. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5029.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Pioglitazone, a peroxisome proliferator-activated receptor (PPAR) γ, is used to treat patients with type 2 diabetes. Recent studies have reported that pioglitazone has potent antiinflammatory and atheroprotective effects on vascular tissue and may reduce cardiovascular risk in patients with diabetes. However, it is unclear if pioglitazone is associated with retinal vascular diseases, i.e., diabetic retinopathy. Because we recently reported on the impaired retinal microcirculation in patients with type 2 diabetes, it is necessary to evaluate the effect of pioglitazone on retinal microcirculation. We examined the direct effect and the underlying mechanism of the vasomotor action of pioglitazone in porcine retinal arterioles.

Methods: : Porcine retinal arterioles (60-90 µm in internal diameter) were isolated, cannulated, and pressurized (55 cmH2O) without flow in this in vitro study. Videomicroscopic techniques were used to record diameter changes in response to pioglitazone.

Results: : The retinal arterioles dilated in a dose-dependent manner in response to pioglitazone (10 n-10 µM). This vasodilation decreased by 60% after removal of the endothelium (p<0.0001). The nitric oxide (NO) synthase inhibitor N-nitro-L-arginine methyl ester, L-NAME, (10 µM) inhibited the effect of pioglitazone-induced vasodilation comparable to that produced by denudation (p<0.0001). A nonselective K-channel blocker, tetraethylammonium, and a voltage-gated K (K+) channel inhibitor, 4-AP, inhibited vasodilation (p<0.0001 for both comparisons). Co-administration of L-NAME and 4-AP almost eliminated the vasodilation induced by pioglitazone (p<0.0001).

Conclusions: : Pioglitazone elicits both endothelium-dependent and independent dilation of the retinal arterioles. The current findings suggest that endothelium-dependent and independent vasodilation induced by pioglitazone is mediated by the released NO and activation of the K+ channels, respectively.

Keywords: diabetic retinopathy • nitric oxide • drug toxicity/drug effects 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.